scispace - formally typeset
J

Josep Maria Arnau

Researcher at University of Barcelona

Publications -  44
Citations -  1368

Josep Maria Arnau is an academic researcher from University of Barcelona. The author has contributed to research in topics: Clinical trial & Medical prescription. The author has an hindex of 17, co-authored 44 publications receiving 1290 citations. Previous affiliations of Josep Maria Arnau include Bellvitge University Hospital & Autonomous University of Barcelona.

Papers
More filters
Journal ArticleDOI

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study

Enrique Galve, +6 more
- 01 Apr 1996 - 
TL;DR: Intravenous amiodarone, at the doses used in this study, produces a modest but not significant benefit in converting acute atrial fibrillation to sinus rhythm.
Journal ArticleDOI

Perfil da automedicação no Brasil

Paulo Sérgio Dourado Arrais, +5 more
- 01 Feb 1997 - 
TL;DR: Os dados sugerem that a automedicacao no Brasil reflete as carencias e habitos da populacao, e consideravelmente influenciADA pela prescricao medica e tem a sua qualidade prejudicada pela baixa seletividade do mercado farmaceutico.
Journal ArticleDOI

A critical review of guidelines for low back pain treatment

Josep Maria Arnau, +5 more
- 01 May 2006 - 
TL;DR: A small number of the available guidelines for low back pain treatment achieved acceptable results for specific quality criteria, but the methods to develop the guidelines’ therapeutic recommendations need to be more rigorous, more explicit and better explained.
Journal ArticleDOI

β-Adrenergic Blocking Agents in Heart Failure: Benefits of Vasodilating and Nonvasodilating Agents According to Patients' Characteristics: A Meta-analysis of Clinical Trials

Sara Bonet, +6 more
- 13 Mar 2000 - 
TL;DR: In patients with heart failure, b-blockers reduce total and cardiovascular mortality at the expense of a decrease in mortality due to pump failure and sudden death, similar in patients with IHD and in those with non-IHD.
Journal ArticleDOI

Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission

Consuelo Pedrós, +6 more
- 01 Mar 2014 - 
TL;DR: Over 4% of urgent hospitalizations are caused by ADRs, which are dose-related and predictable in more than 90 % of cases, and the main risk factors are advanced age and polypharmacy.